Observational, Non-interventional Biomarker and Endotyping Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPrenosis, Inc.
About this trial
The goal of this observational study is to establish a centralized ARDS biorepository of longitudinal biospecimens and harmonized clinical data, develop unsupervised, therapy-agnostic endotyping algorithms, and develop unsupervised, therapy-specific treatment-prediction algorithms over a 24 month period.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years
ARDS Diagnosis (New Global Definition of ARDS)
Timing: Acute onset within 7 days
Radiology: Bilateral pulmonary opacities
Disqualifiers
None
Trial population
Adults with clinically defined acute respiratory distress syndrome (ARDS)
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Number of Participants with an ARDS Diagnosis
Adults with clinically defined ARDS receiving ICU-level care
Time frame
from enrollment to 28-day in-hospital mortalitySponsors and contacts
Click on the lead sponsor to view all of their trials.
Prenosis, Inc.
Lead sponsor
Biomedical Advanced Research and Development Authority
Collaborator
Source ClinicalTrials.gov